MedPath

A prospective, randomised study of "back light system" for picking up specimens in EUS-FNA

Phase 2
Conditions
pancreatic mass
Registration Number
JPRN-UMIN000013393
Lead Sponsor
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Brief Summary

A total of 80 consecutive patients were eligible during the study period. Adequacy was observed for 52 specimens (65%) with the BLS and 54 (68%) without the BLS (p=0.88). In assessment of specimen adequacy on gross examination, only fair agreement was observed both with and without BLS (kappa score 0.40 and 0.29, respectively).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with pancreatic mass which we cannot detect by EUS Patients with severe ascites Patients with other fatal disease Patients who have risk of bleeding Patients who do not agree to participate in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The adequacy rate in each group.
Secondary Outcome Measures
NameTimeMethod
Gross visual assessment of specimen adequacy, accuracy rate of EUS-FNA and adequacy rates of each time in each endosonographer.
© Copyright 2025. All Rights Reserved by MedPath